Community/Retail

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, talks about the benefits and risks of insulin therapy.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, describes some ways in which pharmacists can help patients with type 2 diabetes mellitus manage their disease.

Joseph Saseen, PharmD, FASHP, FCCP, FNLA, BCPS, CLS, professor in the Departments of Clinical Pharmacy and Family Medicine at University of Colorado Skaggs School of Pharmacy, talks about the new knowledge surrounding hypertension that we have learned in the past 5 to 10 years.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, describes some components of a healthy therapeutic lifestyle change.

Joseph Saseen, PharmD, FASHP, FCCP, FNLA, BCPS, CLS, professor in the Departments of Clinical Pharmacy and Family Medicine at University of Colorado Skaggs School of Pharmacy, talks about the role age plays in deciding blood pressure goals.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, explains what a diabetic comprehensive plan is.

Joseph Saseen, PharmD, FASHP, FCCP, FNLA, BCPS, CLS, professor in the Departments of Clinical Pharmacy and Family Medicine at University of Colorado Skaggs School of Pharmacy, highlights some of the differences between JNC 8 and the American Society of Hypertension guidelines.

Jennifer Costello, PharmD, BCPS, BC-ADM, ambulatory care clinical pharmacist in the Internal Medicine Faculty Practice at Saint Barnabas Medical Center in Livingston, New Jersey, details some common themes between the ADA and AACE guidelines.

NCPA supports this legislation in the hope that it can help achieve a better balance to reduce prescription drug abuse while ensuring those patients with chronic, debilitating pain have access to essential medications.